Multimodality Imaging for Assessment of Myocardial Viability: Nuclear, Echocardiography, MR, and CT

The assessment of myocardial viability may be an important component of the evaluation of patients with coronary artery disease and left ventricular dysfunction. The primary goal of viability assessment in such patients is to guide therapeutic decisions by determining which patients would most likely benefit from revascularization. In patients with chronic coronary artery disease, left ventricular dysfunction may be a consequence of prior myocardium infarction, which is an irreversible condition, or reversible ischemic states such as stunning and hibernation. Imaging techniques utilize several methods to assess myocardial viability: left ventricular function, morphology, perfusion, and metabolism. Each technique (echocardiography, nuclear imaging, magnetic resonance imaging, and x-ray computed tomography) has the ability to assess one or more of these parameters. This article describes how each of these imaging modalities can be used to assess myocardial viability, and reviews the relative strengths and limitations of each technique.

[1]  Jeroen J. Bax,et al.  Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. , 1998, Journal of the American College of Cardiology.

[2]  C. O'connor,et al.  Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.

[3]  R. Bonow,et al.  Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. , 1999, Journal of the American College of Cardiology.

[4]  M. Schwaiger,et al.  Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. , 1994, Circulation.

[5]  V. Dilsizian 18F-FDG Uptake as a Surrogate Marker for Antecedent Ischemia , 2008, Journal of Nuclear Medicine.

[6]  H. Schelbert,et al.  Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.

[7]  D. Berman,et al.  Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[8]  J. Oh,et al.  Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. , 1998, Journal of the American College of Cardiology.

[9]  M. Phelps,et al.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.

[10]  M Schwaiger,et al.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. , 1997, Journal of the American College of Cardiology.

[11]  C. Indolfi,et al.  Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation , 2001, Heart.

[12]  V. Dilsizian,et al.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. , 1990, The New England journal of medicine.

[13]  S. Bergmann,et al.  Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. , 2001, The American journal of cardiology.

[14]  S. Kaul,et al.  Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[15]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[16]  H. Schelbert,et al.  Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[17]  J. Mattera,et al.  Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. , 1999, Circulation.

[18]  V. Dilsizian,et al.  Imaging myocardial metabolism and ischemic memory , 2008, Nature Clinical Practice Cardiovascular Medicine.

[19]  V. Dilsizian,et al.  Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia , 2005, Circulation.

[20]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[21]  V. Dilsizian,et al.  PET myocardial perfusion and metabolism clinical imaging , 2009 .

[22]  W. Zoghbi,et al.  Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.

[23]  M. Verani,et al.  Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography: Comparison With Dobutamine Echocardiography and Thallium-201 Scintigraphy , 2003, Circulation.

[24]  J. Griffith,et al.  Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.

[25]  F. Bénard,et al.  Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. , 2009, JACC. Cardiovascular imaging.

[26]  A. Soricelli,et al.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. , 1996, Circulation.

[27]  Jeroen J. Bax,et al.  Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. , 2001, The American journal of cardiology.

[28]  Jeroen J. Bax,et al.  No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. , 2001, Journal of the American College of Cardiology.

[29]  A. Weyman,et al.  Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. , 1995, Circulation.

[30]  V. Dilsizian,et al.  Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction. , 1998, The American journal of cardiology.

[31]  V. Dilsizian,et al.  [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? , 1998, Circulation.

[32]  M. Schwaiger,et al.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. , 1992, Journal of the American College of Cardiology.

[33]  Allen J. Taylor,et al.  Viability imaging by cardiac computed tomography. , 2010, Journal of cardiovascular computed tomography.

[34]  T. Marwick,et al.  Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. , 1992, The American journal of cardiology.

[35]  Raymond Y Kwong,et al.  Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Imaging in Assessing Myocardial Viability , 2008, Topics in magnetic resonance imaging : TMRI.

[36]  R. Sciagrà,et al.  Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated spect versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[37]  Stefan Neubauer,et al.  Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization , 2004, Circulation.

[38]  Jeroen J. Bax,et al.  Prognostic role of dobutamine stress echocardiography in myocardial viability , 2006, Current opinion in cardiology.

[39]  G. Rodriguez-Granillo,et al.  Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. , 2009, JACC. Cardiovascular imaging.

[40]  G. Gioia,et al.  Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction , 1996, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[41]  Eckart Fleck,et al.  Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery , 2004, Circulation.

[42]  S L Bacharach,et al.  13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. , 1999, Journal of the American College of Cardiology.

[43]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[44]  N. Mullani,et al.  Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  V. Dilsizian Myocardial viability: contractile reserve or cell membrane integrity? , 1996, Journal of the American College of Cardiology.

[46]  M. Penicka,et al.  Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. , 2007, European Heart Journal.

[47]  Jeroen J. Bax,et al.  Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. , 2001, The American journal of cardiology.

[48]  P. Franken,et al.  BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction , 1999, The International Journal of Cardiac Imaging.

[49]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[50]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.

[51]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[52]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.

[53]  André Lamy,et al.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.

[54]  H. Schelbert,et al.  Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. , 1998, Journal of the American College of Cardiology.

[55]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[56]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[57]  G. Beller,et al.  Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. , 1997, Circulation.

[58]  V. Dilsizian Cardiac magnetic resonance versus spect: are all noninfarct myocardial regions created equal? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[59]  V. Dilsizian,et al.  Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue? , 2006, Current opinion in cardiology.